Genetic Risk in Insurance Field.

Paola Bin,Adelaide Conti,Emanuele Capasso,Piergiorgio Fedeli,Fabio Policino,Claudia Casella,Mariano Paternoster

doi:10.1515/med-2018-0045

Abstract

The risk-delimiting tools available to insurance companies are therefore substantial and it is also possible to argue that a margin of uncertainty is a natural component of the insurance contract.Despite this, businesses look at the potential of predictive medicine, and in particular the growing understanding of genetic mechanisms that support many common diseases.In particular, the rapid development of genetics has led many insurance companies to glimpse in the predictive diagnosis of disease by genetic testing the possibility of extending the calculation of the individual risk of developing a particular disease to appropriate premiums or even denying insurance coverage.

Highlights

For some years, in Europe and Italy, there has been a gradual increase in the number of individual citizens taking out supplementary insurance policies on top of the basic health care system [1]
An insurance contract rides on the insurer’s liability to pay a policy of compensation to the insured person if a pre-determined event occurs in a given time period, and by obtaining from the insured a sum of money
The amount of the premium for the individual insured is calculated by taking into account the sum insured and the probability that the insured event will occur during the term of the contract

Summary

Introduction

In Europe and Italy, there has been a gradual increase in the number of individual citizens taking out supplementary insurance policies on top of the basic health care system [1]. Risk factors are evaluated through a classification selection process according to each insured person on the basis of different predefined parameters which corresponds to a given contribution represented by the insurance premium.

Results

Conclusion